DAFTAR PUSTAKA

1. Kirss F, Lang K, Toompere K, Veerus P. Prevalence and risk factors of urinary

incontinence

among

Estonian

postmenopausal

women,

SpringerPlus

2013;2:524.
2. Suparman E, Rompas J. Inkontinensia urin pada wanita menopause. Maj
Obstet Ginekol Indones 2007;32:48-54.
3. Fritel X, Ringa V, Quiboeuf E, Fauconnier A. Female urinary incontinence
from

pregnancy

pathophysiologic

to

menopause,

findings.

Acta

review

of

Obstetricia

epidemiologic
et

and

Gynecologica

Scandinavica2010;1:20
4. Cerruto MA, DElia C, Aloisi A, Fabrello M, Artibani W. Prevalence, incidence,
and obstetric factors impact on female urinary incontinence in Europe: a
systematic review. Urol Int 2013;90(1);1-9.
5. Legendre G, Ringa V, Fauconnier A, Fritel X. Menopause, hormone
treatment, and urinary incontinence at midlife. Maturitas 2013;74(1):26-30.
6. Lang JH, Zhu L, Sun ZJ, Chen J. Estrogen levels and estrogen receptors in
patients with stress urinary incontinence and pelvic organ prolapse. Int j
Gynaecol Obstet 2003;80(1): 35-39.
7. Prawirohardjo S. 2008. Ilmu Kandungan Ed2, Cet.6. Jakarta : PT Bina
Pustaka.
8. Lazari MFM. Esterogen Receptors and Function in the Male Reproductive
System. In Endocrinol Metab. 2009;53(8):923-33
9. Mendelsohn ME, Karas RH. Mechanism of Disease: The Protective Effects of
Esterogen on the Cardiovascular System 1999.
10. Lund JDD, Estrogen reseptor. Denmark: Departement of Chemistry University
of Aahus. 2005.
11. Fernandes DN. Hubungan Antara Inkontinensia Urin dengan Derajat Depresi
pada wanita usia lanjut. Fakultas Kedokteran Universitas sebelas maret
Surakarta 2010.
12. Jaya DU, Rachmadi D. Inkontinensia Urin. Fakultas Kedokteran Universitas
Padjajaran Rumah sakit Hasan Sadikin Bandung 2009.
13. Inkontinensia urine Tipe stress. Buku Ajar Uroginekologi Indonesia. Himpunan
Uroginekologi Rekonstruksi Indonesia 2011;11:75-91

14. Steers WD. Pathophysiology of Overactive Bladder and Urge Urinary

Incontinence. Rev Urol. 2002;4(4):7-18.
15. Ewies AA, Alfhaily F. Topical Vaginal esterogen therapy in managing
postmenopausal urinary 363 symptoms: a reality or a gimmick. Climacteric
2010; 13: 405-418.
16. Carr LK. Hormone Replacement therapy has no routine role in the
management of postmenopausal voiding dysfunction. Can UrolAssoc J.
2009;3(2): 153-155.
17. Valeri A, Brain KL, Young JS, Sgargli G, Pessina F. Effect of 17-estradiol on
rat detrusor smooth muscle contractility. ExpPhysiol 2009; 1:1-32
18. Hlatky MA, Boothroyd D, Vittinghoff E, Sharp P, Whooley MA. Quality-of-life
and depressive symptoms in post menopausal women after receiving
hormone therapy: result from the Heart and Estrogen/ Progestin Replacement
Study (HERS) trial. JAMA 2002; 287(5)591-597
19. Cody JD, RichardsonK, Moehrer B, Hextall A, Glazener CM. Estrogen therapy
for urinary incontinence in post menopausal women. Cochrane Database
Syst Rev 2009; 7(4): 5-14.
20. Lee S, Kang DW. Hudgins-Spivey S, Krust A, Lee EY, Koo Y, et al. Thecaspecific estrogen receptor-alpha knockout mice lose fertility prematurely.
Endocrinology 2009; 150(8) 3855-3862.
21. Welton A. Health realted quality of life after combined hormone replacement
therapy: a randomized controlled trial. BMJ 2008; 337: 1-5.
22. Cardozo L, Lose G, McClish D & Versi E. A systematic review of the effects of
estrogens for symptoms suggestive of overactive bladder. Acta Obstetricia et
Gynecologica Scandinavica 2014; 83:892-897.